Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
UBS
Express Scripts
US Department of Justice
Queensland Health
Chubb
Colorcon
McKesson
Novartis
Cerilliant

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020625

« Back to Dashboard

NDA 020625 describes ALLEGRA, which is a drug marketed by Sanofi Aventis Us and is included in five NDAs. It is available from one supplier. There are five patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ALLEGRA profile page.

The generic ingredient in ALLEGRA is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
Summary for 020625
Tradename:ALLEGRA
Applicant:Sanofi Aventis Us
Ingredient:fexofenadine hydrochloride
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength60MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 25, 1996TE:RLD:No
Patent:➤ SubscribePatent Expiration:Sep 14, 2017Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020625

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cipla
Express Scripts
Fuji
Argus Health
QuintilesIMS
US Department of Justice
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot